Silvia Bio Raises £3 Million in Seed Funding
Silvia Bio, a company based in Sheffield, South Yorkshire, has successfully raised £3 million in a seed funding round. The investment was led by Northern Gritstone, with participation from Parkwalk, the UK Innovation & Science Seed Fund, and Wren Capital.
Advancing Biomanufacturing
Silvia Bio is focused on accelerating biomanufacturing processes through its innovative cell profiling platform and precision media additives. Their technology is designed to enhance both the titre and quality of biologic products derived from mammalian cells, potentially reducing the cost of producing biologic drugs.
Leadership and Vision
The company was co-founded by Ed Curry, who serves as the Chief Executive Officer, alongside Melinda Pohle, the Chief Scientific Officer, and Adam Brown. These founders have driven Silvia Bio's mission to improve the efficiency and cost-effectiveness of biomanufacturing.
Strategic Use of Funds
The newly secured funds will be directed towards further development of Silvia Bio's technology, as well as scaling operations to meet growing demand. This investment will likely support efforts to refine their platform and expand their market reach.
With this injection of capital, Silvia Bio is well-positioned to advance its role in the biomanufacturing sector, offering innovative solutions to enhance the production of biologic drugs.